Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of sufentanil on ED50 and ED95 of remimazolam anesthesia for laryngeal mask insertion
ChiCTR2200062668Phase 4Not yet recruiting
- Sponsor
- Zhuji People's Hospital of Zhejiang Province
- Start
- Aug 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in general anesthesia comparing R group (remimazolam alone) with SR group (sufentanil + remimazolam) (2 arms). Primary endpoints: Induction success rate of general anesthesia and Time to MOAA/S score ≤ 1. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
remimazolamsufentanil
03
Conditions
general anesthesia
Beyond the preview
Go deeper on ChiCTR2200062668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062668.